1. From the CRC Wessex Medical Oncology Unit, University of Southampton, Southampton; Department of Clinical Haematology, University College Hospital, and Royal Marsden Hospital, London; Department of Haematology, Addenbrooke's Hospital, Cambridge, United Kingdom; Ematologia Ed Autotrapianto di Midollo, Ospedale S Martino, Genova, and Centro Trapianti di Midollo, Ospedale Maggiore di Milano, Milan, Italy; and Second Department of Internal Medicine, Christian Albrechts University, Kiel, Germany.